6.90
0.29%
0.02
시간 외 거래:
6.95
0.05
+0.72%
Mannkind Corp 주식(MNKD)의 최신 뉴스
MannKind (STU:NNFN) Inventories, Raw Materials & Components : €5.8 Mil (As of Sep. 2024) - GuruFocus.com
MannKind Shares Soar to Over 8-Year Highs on United Therapeutics’ Tyvaso Revenue Surge: Retail Is Optimistic - MSN
MannKind Corp director Steven Binder sells $456,563 in stock - Investing.com
Insulin Pump Market Report 2024-2035, Featuring Profiles of Leading Players Including Beta Bionics, CeQur, EOFlow, Insulet, LA Roche, MannKind, Medtronic, Medtrum Technologies and MicroPort - Yahoo Finance
MannKind Corporation (NASDAQ:MNKD) Q3 2024 Earnings Call Transcript - Insider Monkey
MannKind Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Insider Sale: Chief People & Workpl Officer Stuart Tross Sells 5 - GuruFocus.com
MannKind Corp's chief people officer Stuart Tross sells $403,700 in stock - Investing.com Australia
Earnings call: MannKind sees growth and pipeline progress in Q3 2024 - Investing.com
MannKind Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Quantisnow
MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Re - GuruFocus.com
MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
MannKind (MNKD) Q3 2024 Earnings Call Transcript - Yahoo! Voices
MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
MannKind Corp Q3 2024 Earnings: EPS of $0.04 Beats Estimates, Re - GuruFocus.com
MannKind (MNKD) Matches Q3 Earnings Estimates - Yahoo Finance
MannKind: Q3 Earnings Snapshot - Thehour.com
MannKind stock soars to 52-week high, hits $7.38 - Investing.com
MannKind Corp (MNKD) Q3 2024 Earnings Report Preview: What To Lo - GuruFocus.com
MannKind Corp (MNKD) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
International Assets Investment Management LLC Raises Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind (NASDAQ:MNKD) Reaches New 1-Year HighWhat's Next? - MarketBeat
MannKind Stock Surge Pre-Market Fueled by Promising Nintedanib DPI Trial Results, Driving Retail Optimism - Barchart
Creative Planning Reduces Position in MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind Corporation (MNKD) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease - ForexTV.com
MannKind (NASDAQ:MNKD) Sets New 1-Year HighTime to Buy? - MarketBeat
MannKind stock soars to 52-week high, touches $6.93 - Investing.com
MannKind Co. (NASDAQ:MNKD) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
MannKind Corporation Reports 2012 Fourth Quarter and Full Year Financial Results - AOL
SG Americas Securities LLC Takes Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat
Mannkind Corp (MNKD) receives an Outperform rating from Leerink Partners - Knox Daily
Recent Insider Activity Could Benefit 3M Co. (MMM) - Knox Daily
Holdings of Mannkind Corp (MNKD) are aligned with the stars - SETE News
Selling Buzz: Mannkind Corp [MNKD] Chief People & Workpl Officer Tross Stuart A sells 25,000 shares of the company - Knox Daily
Ratios Revealed: Decoding Mannkind Corp (MNKD)’s Financial Health - The Dwinnex
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... By GuruFocus - Investing.com Canada
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... - Yahoo Finance
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Re - GuruFocus.com
Did Mannkind Corp (MNKD) perform well in the last session? - US Post News
Potential Price Increase for Mannkind Corp (MNKD) After Recent Insider Activity - Knox Daily
Mannkind Corp (MNKD) can make a big difference with a little luck - SETE News
Squarepoint Ops LLC Sells 133,926 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
Why MannKind (MNKD) Could Beat Earnings Estimates Again - Yahoo Finance
MannKind (MNKD) Just Overtook the 20-Day Moving Average - Yahoo Finance
MannKind Co. (NASDAQ:MNKD) Shares Purchased by Millennium Management LLC - MarketBeat
MannKind (NASDAQ:MNKD) Shares Up 3.2% - MarketBeat
MannKind Leverages Tyvaso DPI Strength In Pulmonary Market Expansion - Seeking Alpha
Marshall Wace LLP Sells 205,764 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
A better buy-in window may exist right now for Mannkind Corp (MNKD) - SETE News
MannKind's SWOT analysis: inhaled therapeutics firm's stock shows promise amid challenges - Investing.com
More Adults With Type 1 Diabetes Achieved A1C Goal ( - Yahoo Finance
MannKind Co. (NASDAQ:MNKD) Shares Bought by Dark Forest Capital Management LP - MarketBeat
자본화:
|
볼륨(24시간):